ProShare Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

ProShare Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,039	Closed	-$1.97M	–	1676
2018 Q4	$1.97M	Sell	14,039 -2,666	-16%	-$405K	0.01%	577
2018 Q3	$2.85M	Buy	16,705 +566	+4%	+$95.1K	0.02%	535
2018 Q2	$2.8M	Sell	16,139 -623	-4%	-$93.6K	0.02%	560
2018 Q1	$1.93M	Sell	16,762 -2,759	-14%	-$293K	0.01%	624
2017 Q4	$1.64M	Buy	19,521 +1,136	+6%	+$94.7K	0.01%	665
2017 Q3	$1.69M	Buy	18,385 +3,193	+21%	+$248K	0.02%	602
2017 Q2	$1.22M	Buy	15,192 +1,767	+13%	+$97.9K	0.01%	673
2017 Q1	$565K	Sell	13,425 -3,038	-18%	-$125K	0.01%	963
2016 Q4	$529K	Buy	+16,463	New	+$422K	0.01%	1046

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

ProShare Advisors's LOXO Position: Q1 2019 in Review

ProShare Advisors sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 14,039 shares — an estimated $1.97M sold.

ProShare Advisors first reported a position in LOXO in Q4 2016 and held it in 9 quarters. The position peaked at $2.85M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

ProShare Advisors reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
ProShare Advisors sold 14,039 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.97M.
ProShare Advisors first reported a position in Loxo Oncology, Inc in Q4 2016 and held it in 9 quarters.
ProShare Advisors's Loxo Oncology, Inc position peaked at $2.85M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on ProShare Advisors's 13F filing for Q1 2019, filed 15 May 2019.